logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Renal Cell Carcinoma Clinical Management 1st Edition Frédéric D Birkhäuser Md

  • SKU: BELL-4396178
Renal Cell Carcinoma Clinical Management 1st Edition Frédéric D Birkhäuser Md
$ 31.00 $ 45.00 (-31%)

5.0

100 reviews

Renal Cell Carcinoma Clinical Management 1st Edition Frédéric D Birkhäuser Md instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 8.73 MB
Pages: 362
Author: Frédéric D. Birkhäuser MD, Nils Kroeger MD, Allan J. Pantuck MD, MS, FACS (auth.), Steven C. Campbell, Brian I. Rini (eds.)
ISBN: 9781627030618, 9781627030625, 1627030611, 162703062X
Language: English
Year: 2013
Edition: 1

Product desciption

Renal Cell Carcinoma Clinical Management 1st Edition Frédéric D Birkhäuser Md by Frédéric D. Birkhäuser Md, Nils Kroeger Md, Allan J. Pantuck Md, Ms, Facs (auth.), Steven C. Campbell, Brian I. Rini (eds.) 9781627030618, 9781627030625, 1627030611, 162703062X instant download after payment.

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.

Related Products